Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 76 to 90 of 141 results for pneumonia

  1. What is the effectiveness and safety of extended pharmacological venous thromboembolism (VTE) prophylaxis for people who have been discharged after treatment for COVID-19?

    16 years and over who have been discharged after treatment for COVID-19 pneumonia I: extended (2 to 6 weeks) pharmacological VTE...

    Research recommendation
    Published
    10 August 2021

  2. Early mobilisation and optimum positioning of people with acute stroke: How safe and effective is very early mobilisation delivered by appropriately trained healthcare professionals after stroke?

    reduction in complications such as venous thromboembolism and hypostatic pneumonia. There could be benefits for motor and sensory...

    Research recommendation
    Published
    11 May 2022

  3. What is the effectiveness and safety of standard-dose compared with intermediate-dose pharmacological venous thromboembolism (VTE) prophylaxis for people with COVID-19, with or without additional risk factors for VTE?

    Comparator, Outcome) P: patients 16 years and over being treated for COVID-19 pneumonia in hospital or the communitywho have:• no...

    Research recommendation
    Published
    10 August 2021

  4. Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis (TA199)

    Evidence-based recommendations on etanercept (Enbrel), infliximab (Remicade) and adalimumab (Humira) for treating active and progressive psoriatic arthritis in adults.

    Technology appraisal guidance
    Published
    25 August 2010
    View recommendations

    Sections for TA199

  5. How cost effective are fluoride varnish programmes and tooth-brushing schemes?

    pre-cancer, and non dental clinical outcomes such as the prevalence of pneumonia and malnutrition in the elderly. Non-clinical outcomes...

    Research recommendation
    Published
    9 June 2015

  6. How can healthy habits that promote oral health be supported and encouraged in families with children at high risk of poor oral health?

    pre-cancer, and non dental clinical outcomes such as the prevalence of pneumonia and malnutrition in the elderly. Non-clinical outcomes...

    Research recommendation
    Published
    9 June 2015

  7. Oral health for adults in care homes (NG48)

    This guideline covers oral health, including dental health and daily mouth care, for adults in care homes. The aim is to maintain and improve their oral health and ensure timely access to dental treatment.

    NICE guideline
    Published
    5 July 2016
    View recommendations

    Sections for NG48

  8. What community-based interventions are effective and cost effective in improving dietary habits affecting the oral health of children and adults, and in particular those at high risk of poor oral health?

    pre-cancer, and non dental clinical outcomes such as the prevalence of pneumonia and malnutrition in the elderly. Non-clinical outcomes...

    Research recommendation
    Published
    9 June 2015

  9. What community-based interventions are effective and cost effective in improving oral health and reducing oral health inequalities among groups of adults at high risk of poor oral health?

    pre-cancer, and non dental clinical outcomes such as the prevalence of pneumonia and malnutrition in the elderly. Non-clinical outcomes...

    Research recommendation
    Published
    9 June 2015

  10. What community-based interventions are effective and cost effective in improving oral health and reducing oral health inequalities among groups of children at high risk of poor oral health?

    pre-cancer, and non dental clinical outcomes such as the prevalence of pneumonia and malnutrition in the elderly. Non-clinical outcomes...

    Research recommendation
    Published
    9 June 2015

  11. What is the relative effectiveness and cost effectiveness of the different components of multi-component, community-based oral health improvement programmes?

    pre-cancer, and non dental clinical outcomes such as the prevalence of pneumonia and malnutrition in the elderly. Non-clinical outcomes...

    Research recommendation
    Published
    9 June 2015

  12. What community-based interventions are effective and cost effective at improving the uptake of, and reducing inequalities in the use of, dental services by groups of adults and children at high risk of poor oral health?

    pre-cancer, and non dental clinical outcomes such as the prevalence of pneumonia and malnutrition in the elderly. Non-clinical outcomes...

    Research recommendation
    Published
    9 June 2015

  13. Intravenous fluid therapy in adults in hospital (CG174)

    This guideline covers the general principles for managing intravenous (IV) fluid therapy in hospital inpatients aged 16 and over with a range of conditions. It aims to help prescribers understand the optimal amount and composition of IV fluids to be administered and the best rate at which to give them, to improve fluid prescribing and outcomes among people in hospital. It does not cover pregnant women, and those with severe liver or renal disease, diabetes or burns.

    Clinical guideline
    Last updated
    5 May 2017
    View recommendations

    Sections for CG174

  14. Parkinson's disease (QS164)

    This quality standard covers the management of Parkinson’s disease in adults. It does not include treatment of parkinsonism not caused by Parkinson’s disease. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    9 February 2018
    View quality statements

    Sections for QS164

  15. Atopic eczema in under 12s: diagnosis and management (CG57)

    This guideline covers diagnosing and managing atopic eczema in children under 12. It aims to improve care for children with atopic eczema by making detailed recommendations on treatment and specialist referral. The guideline also explains how healthcare professionals should assess the effect eczema has on quality of life, in addition to its physical severity.

    Clinical guideline
    Last updated
    22 September 2025
    View recommendations

    Sections for CG57